The information in this section is intended for visitors outside the United States.
Gilead Sciences Announces Third Quarter 2014 Financial Results
Gilead Sciences to Release Third Quarter 2014 Financial Results on Tuesday, October 28, 2014
Health Canada Issues Notice of Compliance for Gilead’s Harvoni™ (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C
2013 Annual Review